Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future

Core Insights - Orion Corporation estimates that annual net sales of its product Nubeqa® could exceed EUR 1 billion in the future, highlighting its significance as the company's largest product [1] - The company's outlook for 2026 projects net sales between EUR 1,900 million and EUR 2,100 million, with operating profit estimated between EUR 550 million and EUR 750 million [2] - Nubeqa® is identified as the primary driver for net sales and operating profit growth in 2026, with expectations for continued strong sales growth [3] Financial Projections - The estimated net sales for 2026 range from EUR 1,900 million to EUR 2,100 million, indicating a robust growth trajectory for the company [2] - Operating profit for the same period is projected to be between EUR 550 million and EUR 750 million, reflecting the financial health of the company [2] - The outlook does not account for any significant milestone payments, suggesting that the projections are based on core product sales [3] Product Significance - Nubeqa® has become the largest product for Orion, and its financial impact is expected to grow further, prompting the company to provide a sales potential estimate [1] - The sales potential of Nubeqa® is influenced by various factors, including regulatory and market conditions, as well as product indications [1]